1. Service Overview & Global Regulatory Compliance Framework
As an experienced EPCM contractor specialized in biomanufacturing infrastructure, we deliver full‑scope Engineering, Procurement and Construction Management services fully aligned with FDA cGMP (21 CFR Part 210‑211, 21 CFR Part 11), EMA EU‑GMP Annex 1, PIC/S and ICH Q8/Q9/Q10 guidelines for global biologic markets. Our project scope covers greenfield new‑build plants, brownfield compliance retrofits, multi‑product flexible CMO sites and clinical pilot facilities for monoclonal antibodies, recombinant proteins, ADCs, mRNA vaccines and viral vectors. Unlike general‑purpose construction managers without deep biopharma regulatory insight, we resolve typical cross‑border project pain‑points: misalignment between design and FDA/EMA inspection expectations, fragmented multi‑vendor coordination, non‑compliant sanitary workmanship, incomplete audit‑ready documentation and delayed CQV handover. We manage the full project lifecycle from conceptual layout through construction supervision, commissioning and qualification hand‑over, delivering inspection‑ready biomanufacturing facilities for clients targeting US and European marketing authorization.
2. Core Execution Philosophy & Regulatory‑Focused Competitive Advantages
Guided by risk‑based quality by design and front‑loaded regulatory embedding, FDA and EMA compliance requirements are integrated from URS and conceptual design rather than treated as post‑construction remediation.
1.Dual‑jurisdiction regulatory‑driven engineering All layout, sanitary equipment specification, cleanroom grading and utility design satisfy both FDA cGMP expectations and EMA Annex 1 contamination‑control mandates, addressing ALCOA+ data integrity, containment strategy and cleaning‑validation requirements critical for agency inspections.
2.End‑to‑end EPCM transparent project governance We manage design reviews, global procurement qualification, on‑site construction supervision, sanitary orbital welding quality control and cross‑discipline milestone tracking; clients retain contract ownership while our team mitigates interface risks across designers, equipment vendors and local building subcontractors.
3.Bioprocess‑oriented sanitary execution standard Enforce unified sanitary specifications for wetted components, zero‑dead‑leg piping, material traceability and surface finish Ra ≤ 0.4‑0.6 μm throughout fabrication and installation, eliminating common FDA/EMA inspection observations related to hygiene and cross‑contamination control.
4.Pre‑aligned CQV‑ready documentation architecture Drive deliverables toward inspection‑ready DQ/IQ/OQ/PQ deliverables during engineering and construction phases, shortening subsequent qualification cycles and supporting BLA/MAA submission dossiers for biologic product registration.
Compared with conventional general building contractors, our biopharma‑specific EPCM model lowers regulatory non‑conformity risks, reduces costly post‑construction rework and delivers predictable schedule and CAPEX performance for global biomanufacturing projects.
3. Four Integrated EPCM Core Service Modules & Standard Deliverables
Our complete FDA‑and‑EMA‑oriented biomanufacturing EPCM system consists of four interconnected lifecycle modules: regulatory‑aligned engineering & design module, global procurement & vendor management module, site construction & sanitary installation management module, and commissioning‑qualification hand‑over support module.
1.Regulatory‑Aligned Engineering & Design Module Carry out process‑driven conceptual and detailed engineering, BIM‑based cleanroom and MEP layout; produce URS, P&IDs, general‑arrangement drawings, DQ packages and contamination‑control strategy documents reviewed against FDA and EMA guidance. Conduct design gap reviews to eliminate foreseeable inspection deficiencies at drawing stage.
2.Global Procurement & Vendor Management Module Implement vendor qualification for sanitary bioprocess equipment, HVAC, PW/WFI systems and automation hardware; enforce material certification, FAT witness testing and traceability documentation required for US‑EU regulatory audits, coordinate cross‑border logistics and technical specification alignment.
3.Site Construction & Sanitary Installation Management Module Provide full‑time on‑site EPCM supervision for cleanroom enclosure, sanitary piping orbital welding, utility system erection and equipment positioning; perform periodic workmanship audits to enforce cGMP sanitary standards while respecting local building and safety codes of project host countries.
4.Commissioning‑Qualification Hand‑Over Support Module Oversee SAT system linkage testing, support integrated CQV execution, review validation master plans and protocol deliverables, organise mock FDA‑EMA‑style pre‑inspection walk‑throughs and deliver a complete set of English‑language audit‑ready technical archives for biologic regulatory filings.
4. Industrial Application & Full Lifecycle Post‑Hand‑Over Support
Our FDA‑and‑EMA‑compliant EPCM services apply to greenfield commercial biologic plants, brownfield facility GMP upgrading, multi‑product CMO manufacturing bases and clinical‑grade pilot production platforms intended for US and European market access. All project designs adopt modular scalable architecture, reserving expansion interfaces for future capacity increase or new biotherapeutic pipeline introduction without large‑scale facility reconstruction. We provide long‑term follow‑up services including post‑project regulatory consultancy, periodic facility compliance re‑assessment, technical support during official FDA or EMA inspections, and engineering guidance for process‑change and facility‑modification change‑control activities. By combining bioprocess engineering expertise with deep understanding of US‑EU regulatory expectations, our EPCM contracting service helps global biopharma clients control overall project risks, shorten facility‑to‑drug‑filing timelines and build robust biomanufacturing infrastructure that sustains inspection readiness for international regulatory authorities.
